Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral Agents
HIV Clin Trials. 2015 Nov;16(6):236-7.
doi: 10.1080/15284336.2015.1124625.